Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Hirsch IB, Buse JB, Leahy J, et al
Foundayo is a once-daily pill classified as an oral small-molecule GLP-1 receptor agonist, with a different chemical structure from injectable GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), and from oral semaglutide (Rybelsus, the Wegovy pill), which belongs to the same peptide class as the injectables
Dual GIP/GLP-1 Receptor Agonists Tirzepatide (Mounjaro) For Type 2 Diabetes Mounjaros May 13, 2022 approval introduced dual GIP/GLP 1 receptor agonism to type 2 diabetes treatment
A 14 pound dog is equivalent to approximately 6.4 kilogram (kg)
The supplier company is located in Seoul, Seoul, and is one of the leading sellers of listed products
